These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10755567)

  • 1. TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus.
    Mohamed MA; Robertson H; Booth TA; Balupuri S; Kirby JA; Talbot D
    Transplantation; 2000 Mar; 69(5):1002-5. PubMed ID: 10755567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active TGF-beta1 expression in kidney transplantation: a comparative study of cyclosporin-A (CyA) and tacrolimus (FK506).
    Mohamed MA; Robertson H; Booth TA; Balupuri S; Gerstenkorn C; Kirby JA; Talbot D
    Transpl Int; 2000; 13 Suppl 1():S295-8. PubMed ID: 11112017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
    Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
    Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of transforming growth factor-beta1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens.
    Radwan-Oczko M; Boratyńska M; Zietek M; Zołedziewska M; Jonkisz A
    J Periodontol; 2006 May; 77(5):865-73. PubMed ID: 16671880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.
    Pankewycz OG; Miao L; Isaacs R; Guan J; Pruett T; Haussmann G; Sturgill BC
    Kidney Int; 1996 Nov; 50(5):1634-40. PubMed ID: 8914030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential protocol biopsies from renal transplant recipients show an increasing expression of active TGF beta.
    Jain S; Mohamed MA; Sandford R; Furness PN; Nicholson ML; Talbot D
    Transpl Int; 2002 Dec; 15(12):630-4. PubMed ID: 12478410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression.
    Miyagi M; Muramatsu M; Ishikawa Y; Ishii T; Sakai K; Arai K; Aikawa A; Ohara T; Mizuiri M; Hirayama N; Hasegawa A
    Transplant Proc; 2002 Aug; 34(5):1589-90. PubMed ID: 12176497
    [No Abstract]   [Full Text] [Related]  

  • 10. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity.
    Ozdemir BH; Ozdemir FN; Demirhan B; Haberal M
    Transplantation; 2005 Dec; 80(12):1681-5. PubMed ID: 16378061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
    Matl I; Viklický O; Voska L; Lodererová A; Vítko S
    Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients.
    Baczkowska T; Perkowska-Ptasińska A; Sadowska A; Lewandowski Z; Nowacka-Cieciura E; Cieciura T; Pazik J; Lewandowska D; Mroz A; Urbanowicz A; Nazarewski S; Danielewicz R
    Transplant Proc; 2005 Mar; 37(2):773-5. PubMed ID: 15848527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
    Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S
    J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
    Rivelli RF; Gonçalves RT; Leite M; Santos MA; Delgado AG; Cardoso LR; Takiya CM
    Nephrology (Carlton); 2015 Mar; 20(3):168-76. PubMed ID: 25404086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
    Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
    Solez K; Vincenti F; Filo RS
    Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients.
    Coupes BM; Williams S; Roberts IS; Short CD; Brenchley PE
    Nephrol Dial Transplant; 2001 Feb; 16(2):361-7. PubMed ID: 11158413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants.
    Bicknell GR; Williams ST; Shaw JA; Pringle JH; Furness PN; Nicholson ML
    Br J Surg; 2000 Nov; 87(11):1569-75. PubMed ID: 11091247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.